The use of cyclosporin-A in the treatment of B-chronic lymphocytic leukemia

Leukemia. 1995 Feb;9(2):357-9.
No abstract available

Publication types

  • Case Reports
  • Comment
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anemia, Hemolytic, Autoimmune / blood
  • Anemia, Hemolytic, Autoimmune / drug therapy*
  • Anemia, Hemolytic, Autoimmune / etiology
  • Autoimmune Diseases / blood
  • Autoimmune Diseases / drug therapy*
  • Autoimmune Diseases / etiology
  • Cyclosporine / therapeutic use*
  • Disease Progression
  • Drug Resistance
  • Fatal Outcome
  • Female
  • Hemoglobins / analysis
  • Humans
  • Interleukin-2 / pharmacology
  • Leukemia, Lymphocytic, Chronic, B-Cell / complications
  • Leukemia, Lymphocytic, Chronic, B-Cell / pathology
  • Leukemia, Lymphocytic, Chronic, B-Cell / therapy*
  • Lymphoma, B-Cell / drug therapy
  • Lymphoma, B-Cell / pathology
  • Middle Aged
  • Neoplastic Stem Cells / drug effects
  • Recombinant Proteins / pharmacology

Substances

  • Hemoglobins
  • Interleukin-2
  • Recombinant Proteins
  • Cyclosporine